Pharma: Clinic Roundup
Friday, April 20, 2012
Eisai Inc., of Woodcliff Lake, N.J., said results from a Phase III study of adjunctive perampanel for refractory partial-onset seizures were published in Neurology.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.